Axiodis CRO Accelerates its Commercial and Marketing Strategy
Axiodis CRO, a subsidiary of the Oxurion group, announces an acceleration of its commercial and marketing strategy. This initiative includes the recruitment of a dedicated team and the strengthening of its digital presence among European players in biometric services and clinical data management.
Strategic Recruitment and Digital Expansion
Axiodis CRO is hiring a sales executive and a marketing manager to support its growth. These appointments are accompanied by a complete overhaul of the website and the deployment of an enhanced digital marketing strategy. The sales team will focus on high-value segments: pharmaceutical and biotech sponsors seeking biometric solutions, academic institutions for long-term partnerships, and CRO partners for integrated offerings. The company is also revising its offerings and pricing policy to propose modular solutions that include biometrics, eCRF Exagis, and AI services.
Identifying Synergies and Integrating AI
Axiodis CRO confirms it has identified synergies with the target discussed by Oxurion, specialized in clinical operations and regulatory affairs. This complementarity would allow for integrated solutions covering the entire clinical development cycle. Concurrently, the company continues to integrate AI components into the core of its solutions, particularly exploring advanced use cases in natural language processing for medical writing and pharmacovigilance. Two pilot projects are currently underway, including one with HTC Health aimed at transforming nutritional prescription through AI.
